Literature DB >> 9343202

Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo.

Y Kawano1, Y Tanaka, N Misawa, R Tanaka, J I Kira, T Kimura, M Fukushi, K Sano, T Goto, M Nakai, T Kobayashi, N Yamamoto, Y Koyanagi.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) accessory genes including nef, vif, and vpr are important factors that determine the replication and pathogenesis of HIV-1. The state of activation is also important for the replication of HIV-1. We evaluated the properties of nef-, vif-, and vpr-minus macrophage-tropic HIV-1(JR) CSF in primary CD4+ Th1- or Th2-like cell cultures which had been activated through CD3 molecules in the presence of interleukin-2 (IL-2) and IL-12 (Th1-like culture) or IL-4 (Th2-like culture), respectively. In activated Th1- or Th2-like cultures, replication of nef-minus HIV-1(JR-CSF) was markedly lower than that of wild-type HIV-1. Subsequent analysis by site-directed mutagenesis showed that (i) the presence of an acidic amino acid-rich domain (amino acid residues 72 to 75) in the Nef protein was critical for the enhancement of viral DNA synthesis, resulting in increased virus growth rate, and (ii) prolines that form part of Src homology 3 binding domain were not essential for viral replication. We also confirmed the importance of sites by using an HIV-1-infected animal model, the hu-PBL-SCID mouse system, representing HIV-1 replication and pathogenesis in activated CD4+ T cells in vivo. These results indicate that Nef accelerates viral replication in activated CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343202      PMCID: PMC192308     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.

Authors:  M Wiskerchen; C Cheng-Mayer
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

2.  Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases.

Authors:  J Schorr; R Kellner; O Fackler; J Freund; J Konvalinka; N Kienzle; H G Kräusslich; N Mueller-Lantzsch; H R Kalbitzer
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.

Authors:  P Rizza; S M Santini; M A Logozzi; C Lapenta; P Sestili; G Gherardi; R Lande; M Spada; S Parlato; F Belardelli; S Fais
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

5.  The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.

Authors:  J H Simon; M H Malim
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family.

Authors:  M F Nunn; J W Marsh
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  The HIV nef protein associates with protein kinase C theta.

Authors:  B L Smith; B W Krushelnycky; D Mochly-Rosen; P Berg
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

8.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.

Authors:  M E Rogel; L I Wu; M Emerman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

10.  Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity.

Authors:  A Greenway; A Azad; J Mills; D McPhee
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more
  15 in total

1.  Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap.

Authors:  Ana Limón; Noriko Nakajima; Richard Lu; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.

Authors:  T Murakami; T Y Zhang; Y Koyanagi; Y Tanaka; J Kim; Y Suzuki; S Minoguchi; H Tamamura; M Waki; A Matsumoto; N Fujii; H Shida; J A Hoxie; S C Peiper; N Yamamoto
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice.

Authors:  Kei Sato; Taisuke Izumi; Naoko Misawa; Tomoko Kobayashi; Yoshiki Yamashita; Masahide Ohmichi; Mamoru Ito; Akifumi Takaori-Kondo; Yoshio Koyanagi
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

4.  The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.

Authors:  Z Hanna; X Weng; D G Kay; J Poudrier; C Lowell; P Jolicoeur
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Authors:  Elena Priceputu; Zaher Hanna; Chunyan Hu; Marie-Chantal Simard; Patrick Vincent; Steffen Wildum; Michael Schindler; Frank Kirchhoff; Paul Jolicoeur
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.

Authors:  Kei Sato; Naoko Misawa; Mitsuko Fukuhara; Shingo Iwami; Dong Sung An; Mamoru Ito; Yoshio Koyanagi
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

7.  Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.

Authors:  Y Suzuki; Y Koyanagi; Y Tanaka; T Murakami; N Misawa; N Maeda; T Kimura; H Shida; J A Hoxie; W A O'Brien; N Yamamoto
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells.

Authors:  Youichi Suzuki; Naoko Misawa; Chihiro Sato; Hirotaka Ebina; Takao Masuda; Naoki Yamamoto; Yoshio Koyanagi
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

9.  Regions of human immunodeficiency virus type 1 nef required for function in vivo.

Authors:  G M Aldrovandi; L Gao; G Bristol; J A Zack
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 10.  The utilization of humanized mouse models for the study of human retroviral infections.

Authors:  Rachel Van Duyne; Caitlin Pedati; Irene Guendel; Lawrence Carpio; Kylene Kehn-Hall; Mohammed Saifuddin; Fatah Kashanchi
Journal:  Retrovirology       Date:  2009-08-12       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.